HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Consuelo Gajate Selected Research

Pharmaceutical Preparations

8/2017Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.
10/2016The alkylphospholipid edelfosine shows activity against Strongyloides venezuelensis and induces apoptosis-like cell death.
4/2010In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
5/2009Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis.
2/2009Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice.
11/2005Cytotoxicity of an anti-cancer lysophospholipid through selective modification of lipid raft composition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Consuelo Gajate Research Topics

Disease

39Neoplasms (Cancer)
09/2022 - 10/2002
4Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 04/2018
3Multiple Myeloma
01/2020 - 01/2007
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2015 - 02/2009
2Adenocarcinoma
09/2022 - 04/2018
2Neoplasm Metastasis (Metastasis)
01/2020 - 01/2016
2Autoimmune Diseases (Autoimmune Disease)
11/2015 - 10/2002
2Melanoma (Melanoma, Malignant)
04/2013 - 07/2011
2Carcinoma (Carcinomatosis)
05/2006 - 02/2004
1Hypoxia (Hypoxemia)
08/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2018
1Leishmaniasis
08/2017
1Infections
10/2016
1Strongyloidiasis
10/2016
1Ewing Sarcoma (Sarcoma, Ewing)
06/2015
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2010
1Ulcer
05/2009
1Inflammation (Inflammations)
05/2009
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2009
1Cardiotoxicity
05/2009
1Colitis
05/2009
1Edema (Dropsy)
05/2009
1Hematologic Neoplasms (Hematological Malignancy)
03/2009
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
02/2009
1T-Cell Leukemia (Leukemia, T Cell)
01/2009
1Leukemia
01/2009
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
05/2006

Drug/Important Bio-Agent (IBA)

27edelfosineIBA
12/2021 - 10/2002
26LipidsIBA
08/2021 - 10/2002
13Death Domain ReceptorsIBA
05/2021 - 08/2004
9Ether (Diethyl Ether)IBA
08/2021 - 10/2002
8Antineoplastic Agents (Antineoplastics)IBA
08/2021 - 10/2002
6Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2005
6Pharmaceutical PreparationsIBA
08/2017 - 11/2005
5LysophospholipidsIBA
09/2011 - 11/2005
4TubulinIBA
01/2021 - 01/2005
4Phospholipids (Phosphatides)FDA LinkGeneric
05/2014 - 10/2002
3DNA (Deoxyribonucleic Acid)IBA
12/2021 - 10/2002
3CaspasesIBA
04/2018 - 07/2011
2Biological ProductsIBA
01/2022 - 10/2002
2CholesterolIBA
05/2021 - 01/2020
2Bortezomib (Velcade)FDA Link
01/2020 - 07/2008
2fosbretabulin (combretastatin A4)IBA
01/2020 - 10/2018
2Caspase 3 (Caspase-3)IBA
10/2018 - 04/2003
2perifosineIBA
08/2017 - 01/2007
2plitidepsin (aplidine)IBA
07/2008 - 04/2003
1Nicotinamide PhosphoribosyltransferaseIBA
09/2022
1Epithelial Cell Adhesion MoleculeIBA
12/2021
1Mitochondrial Proteins (Mitochondrial Protein)IBA
05/2021
1Arginine (L-Arginine)FDA Link
01/2021
1IntegrinsIBA
01/2020
1Insulin-Like PeptidesIBA
01/2020
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020
1Glycoproteins (Glycoprotein)IBA
01/2020
1Mucin-1 (CA 15-3 Antigen)IBA
01/2020
1pyridineIBA
01/2020
1Proteasome InhibitorsIBA
01/2020
1protein-S-isoprenylcysteine O-methyltransferaseIBA
11/2019
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2018
1indoleIBA
10/2018
1Verapamil (Calan)FDA LinkGeneric
10/2018
1Hydroxyl RadicalIBA
04/2018
1pyrrolidineIBA
04/2018
11-cyano-2,3-epithiopropaneIBA
01/2018
1miltefosine (Impavido)IBA
08/2017
1erucylphosphocholineIBA
08/2017
11- O- hexadecyl- 2- O- methylglycero- 3- lactoseIBA
01/2016
1Ion Channels (Ion Channel)IBA
01/2016
1Therapeutic UsesIBA
01/2016
1CalciumIBA
04/2013
1sanguinarineIBA
04/2013
1Glutathione (Reduced Glutathione)IBA
04/2013
1Dantrolene (Dantrium)FDA LinkGeneric
04/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2011
1Apoptosis Inducing FactorIBA
07/2011
1Adenosine Diphosphate (ADP)IBA
07/2011
1BerberineIBA
07/2011
1Cytochromes c (Cytochrome c)IBA
07/2011
1Adenosine Triphosphate (ATP)IBA
07/2011
1L-SelectinIBA
05/2009
1Indomethacin (Indometacin)FDA LinkGeneric
05/2009
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
05/2009
1Bentonite (Montmorillonite)IBA
05/2009
1Apoptosomes (Apoptosome)IBA
03/2009
1Caspase 8 (Caspase-8)IBA
01/2009
1DepsipeptidesIBA
07/2008
1Thalidomide (Thalomid)FDA Link
07/2008
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2008
1AnthracyclinesIBA
07/2008
1Alkylating AgentsIBA
07/2008
1Choline-Phosphate CytidylyltransferaseIBA
05/2006
1LigandsIBA
03/2005
1naphthaleneIBA
01/2005
1Antimitotic AgentsIBA
01/2005
1AldehydesIBA
02/2004

Therapy/Procedure

15Therapeutics
01/2022 - 10/2002
7Drug Therapy (Chemotherapy)
09/2022 - 10/2002
3Oral Administration
04/2010 - 02/2009
1Subcutaneous Injections
12/2021